Targeting of TNFR2 may be used to treat cancer and autoimmune diseases due to its protective and anti-inflammatory effects on cardiomyocytes, keratinocytes, and oligodendrocytes. The gene discussed is TNFRSF1B; the disease is autoimmune disease.